The Lancet Infectious Diseases in conversation with Podcast Por The Lancet Group arte de portada

The Lancet Infectious Diseases in conversation with

The Lancet Infectious Diseases in conversation with

De: The Lancet Group
Escúchala gratis

Saleha Hassan, Senior Editor at The Lancet Infectious Diseases, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy.

A monthly audio companion to the journal, this podcast covers a broad range of topics, from polio eradication in Africa to COVID-19 vaccines in Hong Kong, the treatment of early syphilis in adults to Mpox in the UK, and more.

© 2026 The Lancet Group Ciencia Ciencias Biológicas Enfermedades Físicas Higiene y Vida Saludable
Episodios
  • Jenny Clarke and Herve Semukunzi

    Jenny Clarke and Herve Semukunzi
    Mar 9 2026

    Dr Jenny Clarke and Herve Semukunzi discuss a study they and colleagues recently published with us titled ‘Infection- and vaccine-induced mpox antibodies: validation of a combined mpox IgG ELISA during the clade 1b outbreak in Rwanda’.

    They also discuss the reasons for the paucity of validated serological assays for mpox, particularly in outbreak regions where they are most urgently needed.

    Click here to read the full article:

    https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00006-X/fulltext

    Continue this conversation on social!
    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv
    Más Menos
    21 m
  • Julia Moore Vogel and Danilo Buonsenso on long COVID

    Julia Moore Vogel and Danilo Buonsenso on long COVID
    Dec 19 2025

    Dr Julia Moore Vogel and Dr Danilo Buonsenso discuss various aspects of long COVID including epidemiology, pathophysiology, underlying mechanisms, management, latest research developments, difficulties in conducting clinical trials, and future research priorities.

    Continue this conversation on social!
    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv
    Más Menos
    28 m
  • In Conversation with Steven Tong and Joshua Davis on adaptive platform trials

    In Conversation with Steven Tong and Joshua Davis on adaptive platform trials
    Oct 23 2025

    Professors Steven Tong and Joshua Davis discuss all aspects of adaptive platform trials including advantages, disadvantages, differences from conventional trials, and tips for setting up and assessing them.

    They also highlight several adaptive platform trials currently in the pipeline that could influence infectious disease clinical practise in the future.

    Click here to read our latest issue

    Continue this conversation on social!
    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv
    Más Menos
    26 m
Todavía no hay opiniones